Panel, Fireside Chat
Unlocking the Mysteries of the Brain
Milken InstituteMargaret Anderson, Adam Ghazali, Alan Jones, Jennifer Bristar, Henry Markham, Mark Schnitzer
- The burden of brain and neurological disorders is projected to increase due to aging populations and a lack of current cures, contrasting with declining rates in cancer and cardiac diseases.
- A global effort is anticipated over the next 10 years, involving the Allen Institute with a $300 million initial commitment and a total projected private philanthropy exceeding $1 billion, alongside the Human Brain Project's billion-euro simulation initiative.
- Technology and software, including video games and wireless EEG, are expected to evolve into therapeutic tools that complement pharmaceuticals, potentially lowering drug doses and enabling real-time diagnosis.
- Future therapeutics may shift toward physiologic approaches, such as deep brain stimulation implants for depression and obesity, prosthetic limbs for paralysis, and seizure detection systems.
- Scientific collaboration is predicted to break down traditional silos, with non-profits acting as "farm teams" to fund proof of theory before transferring concepts to large-scale entities.
- The field faces the challenge that every brain differs across ages, genders, and genetic variants, making mapping impossible without multilevel understanding and global cooperation.
- Industry expectations include a transition to large-scale team science, open data platforms, and new therapeutic categories combining physiologic, pharmacologic, and learning-based approaches.
- Significant financial and logistical investments are underway, including a $200 million new facility in Seattle for the Allen Institute and a global budget estimate of $1 trillion required for full brain understanding.
- Genetic factors are expected to be viewed as threshold setters rather than prescriptive causes, necessitating a focus on polygenic factors and environmental conditions.
- Risks include the rapid obsolescence of scientific data if not converted to value within two to three years, the difficulty of mapping the brain due to its plasticity, and the ethical need to balance technology's impact on brain adaptation.
- Exploratory studies are planned to expand deep brain stimulation to new syndromes, utilize rodent models to understand circuit dysfunction, and apply data clustering to redefine disease classification beyond traditional psychiatric or neurological labels.